tiprankstipranks
Advertisement
Advertisement

HK:2565 Stock Latest News

PegBio Sets August Board Meeting to Approve 2026 Interim Results
Company AnnouncementsPegBio Sets August Board Meeting to Approve 2026 Interim Results
3d ago
2565
PegBio’s Diabetes Drug Paidakang Enters Nationwide Clinical Use, Triggers Second Royalty Milestone
PremiumCompany Announcements
PegBio’s Diabetes Drug Paidakang Enters Nationwide Clinical Use, Triggers Second Royalty Milestone
25d ago
2565
PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic Therapies
PremiumCompany Announcements
PegBio Teams with Rani Therapeutics to Pursue Oral Metabolic Therapies
1M ago
2565
PegBio Diabetes Drug Clears Key Hurdle Toward China Reimbursement Listing
PremiumCompany Announcements
PegBio Diabetes Drug Clears Key Hurdle Toward China Reimbursement Listing
2M ago
2565
PegBio Completes H-Share Full Circulation, Boosting Free Float in Hong Kong
PremiumCompany Announcements
PegBio Completes H-Share Full Circulation, Boosting Free Float in Hong Kong
2M ago
2565
PegBio Clarifies Board Composition and Governance Committee Roles
PremiumCompany AnnouncementsPegBio Clarifies Board Composition and Governance Committee Roles
2M ago
2565
PegBio Wins Strong Shareholder Backing for Capital Moves and Governance Changes at AGM
Premium
Company Announcements
PegBio Wins Strong Shareholder Backing for Capital Moves and Governance Changes at AGM
2M ago
2565
PegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout
Premium
Company Announcements
PegBio Secures First HK$61 Million Royalty as Paidakang Diabetes Drug Enters Active Commercial Rollout
2M ago
2565
PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate
PremiumCompany Announcements
PegBio Sets 2025 AGM to Seek Capital Increase and Broad Share Issuance Mandate
3M ago
2565
PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline
PremiumCompany Announcements
PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline
3M ago
2565
PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process
PremiumCompany Announcements
PegBio’s Diabetes Drug Visepegenatide Reaches Key Milestone in China’s Insurance Access Process
3M ago
2565
PegBio reshapes board as independent director resigns and new candidate proposed
PremiumCompany Announcements
PegBio reshapes board as independent director resigns and new candidate proposed
3M ago
2565
PegBio outlines board composition and governance committee roles
PremiumCompany AnnouncementsPegBio outlines board composition and governance committee roles
3M ago
2565
PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake
Premium
Company Announcements
PegBio Cornerstone Investor Extends Lock-Up on 3.37% H-Share Stake
4M ago
2565
PegBio Advances H Share Full Circulation Plan After CSRC Filing Approval
Premium
Company Announcements
PegBio Advances H Share Full Circulation Plan After CSRC Filing Approval
4M ago
2565
PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026
PremiumCompany Announcements
PegBio’s Long-Acting Diabetes Candidate CR059 Gains Late-Breaking Spotlight at ADA 2026
5M ago
2565
PegBio overhauls company secretary and governance roles ahead of 2026
PremiumCompany Announcements
PegBio overhauls company secretary and governance roles ahead of 2026
5M ago
2565
PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug
PremiumCompany Announcements
PegBio Narrows 2025 Losses and Secures China Approval for Core Diabetes Drug
5M ago
2565
PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China
PremiumCompany Announcements
PegBio Taps Tenry Pharmaceutical for Exclusive Paidakang Commercialization in China
5M ago
2565
PegBio sets March 23 board meeting to approve 2025 annual results
PremiumCompany AnnouncementsPegBio sets March 23 board meeting to approve 2025 annual results
5M ago
2565
PegBio Cuts H-Share Board Lot Size to Boost Liquidity
Premium
Company Announcements
PegBio Cuts H-Share Board Lot Size to Boost Liquidity
5M ago
2565
PegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial
Premium
Company Announcements
PegBio’s Circular RNA GLP-1 Candidate Shows Month-Long Effect in First Human Trial
5M ago
2565

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >